The assessment of oxygen metabolism in the human retina has been a major focus of research in the past of the Section of Ophthalmo-Pharmacology and was already founded by two previous FWF projects.
“The grant will enable our team of researchers and PhD students to continue our research to employ cutting-edge technology and innovative methodologies for assessing and monitoring oxygen levels in the retina.”, so Dr. Gerhard Garhöfer, section head of Ophthalmo-Pharmacology at the Department of Clinical Pharmacology. Moreover, this grant represents a pivotal step towards the translation of new imaging methods usually used in basic research into practical applications. “The basic idea and long term-goal is to develop new imaging modalities that allow for the non-invasive risk stratification of patients with ocular and systemic diseases that are associated with altered oxygen metabolism.” explains Dr. Garhöfer.
„In the long term, we want to develop new imaging techniques that can be used in patients who have ocular and systemic diseases with an altered oxygen metabolism.“